Use of Antiepileptic Drugs in Patients with Chronic Kidney Disease and End Stage Renal Disease

被引：24

作者：

Bansal, Amar D. ^{[1
]}

Hill, Chloe E. ^{[2
]}

Berns, Jeffrey S. ^{[1
]}

机构：

[1] Univ Penn, Renal Electrolyte & Hypertens Div, Perelman Sch Med, Philadelphia, PA 19104 USA

[2] Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA

来源：

SEMINARS IN DIALYSIS | 2015年 / 28卷 / 04期

关键词：

GRANULOMATOUS INTERSTITIAL NEPHRITIS; ANTIDIURETIC-HORMONE SECRETION; HIGH-FLUX HEMODIALYSIS; PROTEIN-BINDING; PERITONEAL-DIALYSIS; PHARMACOKINETICS; CARBAMAZEPINE; LAMOTRIGINE; TOPIRAMATE; GABAPENTIN;

D O I：

10.1111/sdi.12385

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Epilepsy is a disorder with an approximate worldwide prevalence of 1%. Due to complexities of metabolism, protein-binding, renal elimination, and other pharmacokinetic parameters, the dosing of antiepileptic drugs (AEDs) in patients with chronic kidney disease (CKD) or end stage renal disease (ESRD) deserves special attention. This is a review of the most commonly prescribed AEDs with special focus on their indication, pharmacokinetics, and unique considerations for use in patients with CKD and ESRD. A review of their renal toxicities is also included.

引用

页码：404 / 412

页数：9

共 50 条

[41] Diversity of Bacteroidaceae family in gut microbiota of patients with chronic kidney disease and end stage renal disease
Khiabani, Siamak Amini
Haghighat, Setareh
Khosroshahi, Hamid Tayebi
Asgharzadeh, Mohammad
Kafil, Hossein Samadi
HEALTH PROMOTION PERSPECTIVES, 2023, 13 (03): : 237 - 242
[42] Fibrinokinetic Deficit in Chronic Kidney Disease and End Stage Renal Disease Patients Contributes to the Hemostatic Abnormalities
Adiguzel, C.
Cunanan, J.
Hoppensteadt, D.
Bansal, V.
Fareed, J.
CLINICAL CHEMISTRY, 2009, 55 (06) : A78 - A78
[43] Fibrinokinetic Deficit in Chronic Kidney Disease and End Stage Renal Disease Patients Contributes to the Hemostatic Abnormalities
Adiguzal, Cafer
Bansal, Vinod
Cunanan, Josephine
Litinas, Evangelos
Hoppensteadt, Debra
Fareed, Jawed
FASEB JOURNAL, 2009, 23
[44] Obesity and risk of end-stage renal disease in patients with chronic kidney disease: a cohort study
Lin, Ting-Yun
Liu, Jia-Sin
Hung, Szu-Chun
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2018, 108 (05): : 1145 - 1153
[45] RISK OF RECURRENT GASTROINTESTINAL BLEEDING IN ANTICOAGULATED PATIENTS WITH CHRONIC KIDNEY DISEASE AND END STAGE RENAL DISEASE
Khalid, Fatima
Qureshi, Sophia
Alirhayim, Zaid
Alsayegh, Roofan
Hassan, Syed
Mittal, Chetan
Qureshi, Waqas
AMERICAN JOURNAL OF KIDNEY DISEASES, 2013, 61 (04) : A54 - A54
[46] Effects of spironolactone on cardiovascular outcomes in chronic kidney disease and end-stage renal disease patients
Sun, Li-Jing
Xu, Bo
Chen, Shun-Jie
Liu, Shuang
He, Bin
Jiang, Geng-Ru
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (02): : 794 - 803
[47] Evaluation of Warfarin Dose Requirements in Patients with Chronic Kidney Disease and End-Stage Renal Disease
Sakaan, Sami A.
Hudson, Joanna Q.
Oliphant, Carrie S.
Tolley, Elizabeth A.
Cummings, Carolyn
Alabdan, Numan A.
Self, Timothy H.
PHARMACOTHERAPY, 2014, 34 (07): : 695 - 702
[48] Fibrinokinetic deficit in chronic kidney disease and end stage renal disease patients contributes to the hemostatic abnormalities
Bansal, V
Adiguzel, C.
Cunanan, J.
Hoppensteadt, D.
Iqbal, O.
Fareed, J.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 714 - 715
[49] The effect of anemia on developing chronic kidney disease and end stage renal disease in patients with diabetes.
Solid, CA
Gilbertson, DT
Collins, AJ
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 455A - 455A
[50] A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease
Hedayati, S. Susan
Yalamanchili, Venkata
Finkelstein, Fredric O.
KIDNEY INTERNATIONAL, 2012, 81 (03) : 247 - 255

← 1 2 3 4 5 →